CMS will now cov­er pricey CAR-T ther­a­pies for Medicare pa­tients

The Cen­ters for Medicare and Med­ic­aid (CMS) has been busy. Ear­li­er this week, the agency pre­scribed ways to re­sus­ci­tate the fledg­ling an­tibi­ot­ic in­dus­try by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.